Smallpox Vaccination Policy — The Need for Dialogue

Author:
  • AFAnthony S. Fauci
    Anthony S. Fauci

Abstract
The recent cases of anthrax due to bioterrorism and the terrorist attacks of September 11, 2001, have led to an unprecedented degree of concern and urgency regarding the vulnerability of our society to more such attacks.1 At the Department of Health and Human Services, efforts to counter bioterrorism are focused on a group of pathogenic microbes that include Bacillus anthracis (the cause of anthrax), variola virus (the cause of smallpox), Yersinia pestis (the cause of plague), Francisella tularensis (the cause of tularemia), Clostridium botulinum (which causes botulism), and the hemorrhagic-fever viruses such as Ebola.1 Within this group, smallpox stands out because of its ease of transmissibility, its high mortality rate, and its established ability to ravage populations. There is a relative lack of immunity against smallpox in the population, and the thought of a smallpox epidemic instills terror in nearly everyone.2